Inhalt des Dokuments
- © TUB
Gunter Festel is founder and CEO of the investment
firm FESTEL CAPITAL (www.festel-capital.com), which specializes in the
commercialisation of technologies in the areas of energy, environment,
health, materials and nutrition. Furthermore, he co-founded as a
Founding Angel (www.founding-angels.com) various biotechnology
start-ups in Germany and Switzerland. Prior to that, he was a member
of the management team and head of the consulting business for the
chemical and healthcare industry with Arthur D. Little in Zurich and a
consultant with McKinsey. He started his career with Bayer, where he
held various management positions in R&D and marketing.
Gunter Festel holds a MA and PhD in chemistry, a BA in business administration, a MA in economics, a PhD in management & economics and an Executive Master of Corporate Finance. At the Swiss Federal Institute of Technology (ETH) Zurich he heads a scientific working group focused on start-ups/spin-offs (www.start-ups.ethz.ch). He gives lectures at ETH Zurich, the University St. Gallen, the University Dusseldorf, the Kazan State Technical University, the University of Hong Kong and the National University of Singapore. He is chairman of the board of the Association of German Biotechnology Companies (VBU), a member of various advisory boards, consultant to the OECD and reviewer for different institutions (Swiss National Science Foundation, German Federal Ministry for Education and Research, Austrian Federal Ministry of Economy, Family and Youth).